An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE. (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.13455
PubMed Identifier: 29654623
Publication URI: http://europepmc.org/abstract/MED/29654623
Type: Journal Article/Review
Volume: 73
Parent Publication: Allergy
Issue: 12
ISSN: 0105-4538